Eli Lilly will seek to have Mounjaro listed on the scheme this year. If successful, it would mean taxpayer subsidies for the ...

The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.

GLP-1 weight-loss drugs are cutting calories… and grocery bills, according to a new study from Cornell and Numerator.

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Billionaire entrepreneur and top adviser to President-elect Donald Trump, Elon Musk, touted that he has reaped the benefits of Ozempic after fellow top Trump adviser, Robert F. Kennedy Jr., suggested ...

Taking a glp-1 medication for weight loss isn't appropriate for everyone. There are side effects and costs to consider.

I tried anti-obesity medication and these were the surprising side-effects' - When Henry Conway hit his forties his BMI ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

What we eat contributes to obesity. Sedentary lifestyle compounds the problem. That’s why diet and exercise have been on the ...

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...